Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Late stage results from the probe development effort to identify inhibitors of (NADPH oxidase 1) NOX1: HEK/293 percent inhibition
Assay data:11 Active, 42 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
Late-stage radioligand binding assay to identify inhibitors of NADPH oxidase 1 (NOX1): PDSP screen
Assay data:1 Active, 1 Tested
Late-stage radioligand binding dose response assay to identify inhibitors of NADPH oxidase 1 (NOX1): PDSP screen Ki
Late-stage luminescence-based cell-based dose response assay to identify inhibitors of NADPH oxidase 1 (NOX1): Purchased analogs 2
Assay data:6 Active, 2 Activity ≤ 1 µM, 20 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
Late-stage luminescence-based cell-based dose response assay to identify inhibitors of NADPH oxidase 1 (NOX1): Purchased analogs
Assay data:23 Active, 16 Activity ≤ 1 µM, 105 Tested
Late-stage luminescence-based cell-based dose response assay to identify inhibitors of NADPH oxidase 1 (NOX1): Synthesized analogs 3
Assay data:2 Active, 1 Activity ≤ 1 µM, 5 Tested
Late-stage luminescence-based cell-based dose response assay to identify inhibitors of NADPH oxidase 1 (NOX1): Synthesized analogs 2
Assay data:7 Active, 3 Activity ≤ 1 µM, 12 Tested
Late-stage luminescence-based cell-based dose response assay to identify inhibitors of NADPH oxidase 1 (NOX1): Synthesized analogs
Assay data:7 Active, 3 Activity ≤ 1 µM, 14 Tested
Late stage results from the probe development effort to identify inhibitors of (NADPH oxidase 1) NOX1: Xanthine Oxidase
Assay data:2 Active, 6 Tested
Late-stage microscopic assay to identify inhibitors of NADPH oxidase 1 (NOX1): Inhibition of invadopodia formation
Assay data:1 Tested
SummaryPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
Luminescence-based cell-based assay to identify inhibitors of NADPH oxidase 1 (NOX1)
Assay data:68 Active, 96 Tested
Luminescence-based cell-based dose response assay to identify inhibitors of NADPH oxidase 1 (NOX1)
Assay data:16 Active, 14 Activity ≤ 1 µM, 22 Tested
Late stage results from the probe development effort to identify inhibitors of NOX1: HEK/293 IC50
Assay data:6 Active, 3 Activity ≤ 1 µM, 6 Tested
Late stage results from the probe development effort to identify inhibitors of Nox1.
Assay data:64 Active, 96 Tested
siRNA Circadian Assay
Assay data:527 Active, 33364 Tested
SummaryPubMed CitationRelated BioAssays by Depositor
Summary of probe development efforts to identify inhibitors of NADPH oxidase 1 (Nox1)
Assay data:2 Active, 2 Tested
Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of NADPH oxidase 1 (Nox1): Maybridge Library
Assay data:130 Active, 16000 Tested
RNAi screen for vemurafenib enhancer genes in BRAFV600 melanoma - Primary Screen
Assay data:790 Active, 18119 Tested
Summary
Luminescence-based cell-based dose response assay to identify inhibitors of NADPH oxidase 1 (NOX1): Cherry picks 2
Assay data:5 Active, 5 Activity ≤ 1 µM, 5 Tested
Late stage results from the probe development effort to identify inhibitors of NOX1: HEK/293 IC50 Set 2
Assay data:7 Active, 3 Activity ≤ 1 µM, 7 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on